SHILPA MEDICARE share price has plunged 6% and is presently trading at Rs 860.0.
Meanwhile, the BSE HEALTHCARE index is at 43,755.5 .
Among the top losers in the BSE HEALTHCARE index today are FDC (down 5.1%) and GSK Pharma (down 3.6%).
MAX HEALTHCARE INSTITUTE (up 3.5%) and SUVEN PHARMACEUTICALS (up 3.1%) are among the top gainers today.
Over the last one year, SHILPA MEDICARE has moved up from Rs 359.1 to Rs 860.0, registering a gain of Rs 500.9 (up 139.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,755.5, registering a gain of 53.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 167.1%), SUVEN PHARMACEUTICALS (up 113.1%) and Glenmark Pharma (up 95.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 83,264.6 (up 0.4%).
The top gainers among the BSE Sensex today are NTPC (up 2.5%) and Kotak Bank (up 1.9%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.
In the meantime, NSE Nifty is at 25,438.4 (up 0.2%). NTPC and Kotak Bank are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,264.6, registering a gain of 15,667.7 points (up 23.2%).
SHILPA MEDICARE net profit grew 519.2% YoY to Rs 176 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 12.4% to Rs 2,925 million during the period as against Rs 2,602 million in April-June 2023.
For the year ended March 2024, SHILPA MEDICARE reported 203.4% increase in net profit to Rs 320 million compared to net loss of Rs 309 million during FY23. Revenue of the company grew 9.7% to Rs 11,516 million during FY24.
The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 163.4.
Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Plunges 6%; BSE HEALTHCARE Index Down 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!